15-Lipoxygenase-1 production is lost in pancreatic cancer and overexpression of the gene inhibits tumor cell growth

Neoplasia

Volumn 9, Issue 11, 2007, Pages 917-926

  Hennig, René ^a,f   Kehl, Timo ^b,c   Noor, Seema ^b,c   Ding, Xian Zhong ^d   Rao, Sambasiva M ^d   Bergmann, Frank ^b   Fürstenberger, Gerhard ^c   Büchler, Markus W ^b   Friess, Helmut ^a   Krieg, Peter ^c   Adrian, Thomas E ^e  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

15 lipoxygenase 1; Chronic pancreatitis; Pancreatic cancer; Pancreatic intraepithelial neoplasia; Tubular complexes

Indexed keywords

15 LIPOXYGENASE 1; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; ICOSANOID; UNCLASSIFIED DRUG;

ARTICLE; CANCER PREVENTION; CONTROLLED STUDY; DELAYED DIAGNOSIS; ENZYME ANALYSIS; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; ONCOGENE; PANCREAS CANCER; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

EID: 36048949602     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.07565     Document Type: Article

References (47)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, and Thun MJ (2006). Cancer statistics, 2006. CA Cancer J Clin 56, 106-130.
2. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, and Thun MJ (2005). Cancer statistics, 2005. CA Cancer J Clin 55, 10-30.
3. Oomi K and Amano M (1998). The epidemiology of pancreatic diseases in Japan. Pancreas 16, 233-237.
4. Lin Y, Tamakoshi A, Wakai K, Kawamura T, Aoki R, Kojima M, and Ohno Y (1998). Descriptive epidemiology of pancreatic cancer in Japan. J Epidemiol 8, 52-59.
5. Anonymous (2002). Stat bite: pancreatic cancer incidence in U.S. blacks and whites, 1973-1999. J Natl Cancer Inst 94, 1671.
6. Chua YJ and Cunningham D (2005). Adjuvant treatment for resectable pancreatic cancer. J Clin Oncol 23, 4532-4537.
7. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, Beger H, Fernandez-Cruz L, Dervenis C, Lacaine F, et al. (2004). A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350, 1200-1210.
8. Stocken DD, Buchler MW, Dervenis C, Bassi C, Jeekel H, Klinkenbijl JH, Bakkevold KE, Takada T, Amano H, and Neoptolemos JP (2005). Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer 92, 1372-1381.
9. Esposito I, Kayed H, Keleg S, Giese T, Sage EH, Schirmacher P, Friess H, and Kleeff J (2007). Tumor-suppressor function of SPARC-like protein 1/Hevin in pancreatic cancer. Neoplasia 9, 8-17.
10. Hruban RH, Goggins M, Parsons J, and Kern SE (2000). Progression model for pancreatic cancer. Clin Cancer Res 6, 2969-2972.
11. Hruban RH, Adsay NV, Albores-Saavedra J, Compton C, Garrett ES, Goodman SN, Kern SE, Klimstra DS, Kloppel G, Longnecker DS, et al. (2001). Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 25, 579-586.
12. Lohr M, Kloppel G, Maisonneuve P, Lowenfels AB, and Luttges J (2005). Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis. Neoplasia 7, 17-23.
13. Woutersen RA, Appel MJ, and Garderen-Hoetmer A (1999). Modulation of pancreatic carcinogenesis by antioxidants. Food Chem Toxicol 37, 981-984.
14. Woutersen RA, Appel MJ, Garderen-Hoetmer A, and Wijnands MV (1999). Dietary fat and carcinogenesis. Mutat Res 443, 111-127.
15. Rose DP (1997). Dietary fat, fatty acids and breast cancer. Breast Cancer 4, 7-16.
16. Kelavkar UP, Hutzley J, Dhir R, Kim P, Allen KG, and McHugh K (2006). Prostate tumor growth and recurrence can be modulated by the omega-6:omega-3 ratio in diet: athymic mouse xenograft model simulating radical prostatectomy. Neoplasia 8, 112-124.
17. Shureiqi I, Wojno KJ, Poore JA, Reddy RG, Moussalli MJ, Spindler SA, Greenson JK, Normolle D, Hasan AA, Lawrence TS, et al. (1999). Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers. Carcinogenesis 20, 1985-1995.
18. Ding XZ and Adrian TE (2001). Role of lipoxygenase pathways in the regulation of pancreatic cancer cell proliferation and survival. Inflammopharmacology 9, 157-164.
19. Ding XZ, Hennig R, and Adrian TE (2003). Lipoxygenase and cyclooxygenase metabolism: new insights in treatment and chemoprevention of pancreatic cancer. Mol Cancer 2, 10.
20. HsiL C, Wilson L, Nixon J, and Eling TE(2001). 15-Lipoxygenase- 1metabolites down-regulate peroxisome proliferator-activated receptor gamma via the MAPK signaling pathway. J Biol Chem 276, 34545-34552.
21. Funk CD (1996). The molecular biology of mammalian lipoxygenases and the quest for eicosanoid functions using lipoxygenase-deficient mice. Biochim Biophys Acta 1304, 65-84.
22. Shureiqi I and Lippman SM (2001). Lipoxygenase modulation to reverse carcinogenesis. Cancer Res 61, 6307-6312.
23. Furstenberger G, Krieg P, Muller-Decker K, and Habenicht AJ (2006). What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis? Int J Cancer 119, 2247-2254.
24. Adrian TE, Ding X-Z, and Tong W-G (2001). The mitogenic effect of 5-lipoxygenase metabolite, 5-HETE on pancreatic cancer cell proliferation through activation of multiple signaling pathways. FASEB J 15, A1163.
25. Hennig R, Ding XZ, Tong WG, Schneider MB, Standop J, Friess H, Buchler MW, Pour PM, and Adrian TE (2002). 5-Lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue. Am J Pathol 161, 421-428.
26. Hennig R, Grippo P, Ding XZ, Rao SM, Buchler MW, Friess H, Talamonti MS, Bell RH, and Adrian TE (2005). 5-Lipoxygenase, a marker for early pancreatic intraepithelial neoplastic lesions. Cancer Res 65, 6011-6016.
27. Shureiqi I, Xu X, Chen D, Lotan R, Morris JS, Fischer SM, and Lippman SM (2001). Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression. Cancer Res 61, 4879-4884.
28. Shureiqi I, Chen D, Lotan R, Yang P, Newman RA, Fischer SM, and Lippman SM (2000). 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells. Cancer Res 60, 6846- 6850.
29. Wu J, Xia HH, Tu SP, Fan DM, Lin MC, Kung HF, Lam SK, and Wong BC (2003). 15-Lipoxygenase-1 mediates cyclooxygenase-2 inhibitor-induced apoptosis in gastric cancer. Carcinogenesis 24, 243-247.
30. Heslin MJ, Hawkins A, Boedefeld W, Arnoletti JP, Frolov A, Soong R, Urist MM, and Bland KI (2005). Tumor-associated down-regulation of 15-lipoxygenase-1 is reversed by celecoxib in colorectal cancer. Ann Surg 241, 941-946.
31. Jiang WG, Watkins G, Douglas-Jones A, and Mansel RE (2006). Reduction of isoforms of 15-lipoxygenase (15-LOX)-1 and 15-LOX-2 in human breast cancer. Prostaglandins Leukot Essent Fatty Acids 74, 235-245.
32. Kim JS, Baek SJ, Bottone FG Jr, Sali T, and Eling TE (2005). Overexpression of 15-lipoxygenase-1 induces growth arrest through phosphorylation of p53 in human colorectal cancer cells. Mol Cancer Res 3, 511-517.
33. Hsi LC, Wilson LC, and Eling TE (2002). Opposing effects of 15-lipoxygenase-1 and -2 metabolites on MAPK signaling in prostate. Alteration in peroxisome proliferator - activated receptor gamma. J Biol Chem 277, 40549-40556.
34. Kelavkar UP, Parwani AV, Shappell SB, and Martin WD (2006). Conditional expression of human 15-lipoxygenase-1 in mouse prostate induces prostatic intraepithelial neoplasia: the FLiMP mouse model. Neoplasia 8, 510-522.
35. Hsi LC, Xi X, Wu Y, and Lippman SM (2005). The methyltransferase inhibitor 5-aza-2-deoxycytidine induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells. Mol Cancer Ther 4, 1740-1746.
36. Bligh EG and Dyer WJ (1959). A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37, 911-917.
37. Balkwill F and Mantovani A (2001). Inflammation and cancer: back to Virchow? Lancet 357, 539-545.
38. Crowell PL, Schmidt CM, Yip-Schneider MT, Savage JJ, Hertzler DA, and Cummings WO (2006). Cyclooxygenase-2 expression in hamster and human pancreatic neoplasia. Neoplasia 8, 437-445.
39. DuBois RN (2000). Review article: cyclooxygenase - a target for colon cancer prevention. Aliment Pharmacol Ther 14 (Suppl 1), 64-67.
40. Marnett LJ and DuBois RN (2002). COX-2: a target for colon cancer prevention. Annu Rev Pharmacol Toxicol 42, 55-80.
41. Kelavkar UP and Cohen C (2004). 15-Lipoxygenase-1 expression upregulates and activates insulin-like growth factor-1 receptor in prostate cancer cells. Neoplasia 6, 41-52.
42. Shureiqi I, Zuo X, Broaddus R, Wu Y, Guan B, Morris JS, and Lippman SM (2007). The transcription factor GATA-6 is overexpressed in vivo and contributes to silencing 15-LOX-1 in vitro in human colon cancer. FASEB J 21(3), 743-753.
43. Shureiqi I, Jiang W, Fischer SM, Xu X, Chen D, Lee JJ, Lotan R, and Lippman SM (2002). GATA-6 transcriptional regulation of 15-lipoxygenase-1 during NSAID-induced apoptosis in colorectal cancer cells. Cancer Res 62, 1178-1183.
44. Deguchi A, Xing SW, Shureiqi I, Yang P, Newman RA, Lippman SM, Feinmark SJ, Oehlen B, and Weinstein IB (2005). Activation of protein kinase G up-regulates expression of 15-lipoxygenase-1 in human colon cancer cells. Cancer Res 65, 8442-8447.
45. Liu C, Xu D, Sjoberg J, Forsell P, Bjorkholm M, and Claesson HE (2004). Transcriptional regulation of 15-lipoxygenase expression by promoter methylation. Exp Cell Res 297, 61-67.
46. Hsi LC, Xi X, Lotan R, Shureiqi I, and Lippman SM (2004). The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells. Cancer Res 64, 8778-8781.
47. Shureiqi I, Wu Y, Chen D, Yang XL, Guan B, Morris JS, Yang P, Newman RA, Broaddus R, Hamilton SR, et al. (2005). The critical role of 15-lipoxygenase-1 in colorectal epithelial cell terminal differentiation and tumorigenesis. Cancer Res 65, 11486-11492.